Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials (Q35052434)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials |
scientific article |
Statements
1 reference
Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials (English)
1 reference
Peter Q Eichacker
1 reference
Charles Natanson
1 reference
1 January 2003
1 reference
1 reference
31
1 reference
1 Suppl
1 reference
S94-6
1 reference
Identifiers
1 reference
1 reference